Partager :

Un laboratoire de pathologie à Porto Rico devient le premier du continent américain à utiliser un logiciel fondé sur l’intelligence artificielle développé par la start-up israélienne Ibex Medical Analytics pour la détection du cancer de la prostate.

CorePlus Servicios Clínicos y Patológicos, LLC, un laboratoire de pathologies cliniques et anatomiques, a annoncé mardi la première installation de la technologie de pathologie numérique dans ses principales infrastructures à Carolina, une municipalité située sur la côte nord-est de Porto Rico. (Times of Israel)

LE PLUS.

Ibex Medical Analytics, a pioneering developer of AI-powered cancer diagnostics, is announcing today its research collaboration with UPMC and digital pathology expert Dr. Liron Pantanowitz, Professor of Pathology and Biomedical Informatics and Vice Chairman of Pathology Informatics at UPMC Shadyside.

In this collaboration, UPMC and Ibex will apply the Ibex Second Read™ (SR) system on prostate core needle biopsies (PCNBs) from UPMC to further validate the performance characteristics of the AI-driven system in prostate cancer diagnosis.

The Ibex SR system has recently been announced as the first AI-driven diagnostic application in pathology to be applied in a clinical setting. It is deployed in the pathology institute of Maccabi Healthcare Services, one of the largest healthcare providers in Israel and Ibex’s strategic partner.

« The advent of digital pathology enables the implementation of AI-driven technologies to ensure more accurate and rapid cancer diagnosis in pathology institutes. We believe that systems such as the one developed by Ibex have an important role in advancing routine anatomic pathology practice. We will be assessing the performance of the Ibex Second Read system to determine its potential for implementation at UPMC, » stated Dr. Pantanowitz.

Partager :